Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

University of Louisville87 enrolled

Overview

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Breast Cancer

Interventions

bubble packaging for monthly prescriptionOTHER

Monthly bubble packaging among women prescribed anti-estrogens

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * Estrogen receptor positive (\> 1% estrogen expression) by immunohistochemistry * Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy Exclusion Criteria: * Patients with metastatic disease (stage IV) * Patients less than 18 years of age * Prisoners * Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Locations (1)

James Graham Brown Cancer Center-University of Louisville

Louisville, Kentucky, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.